Sharon Hoover
Family · Sebring, FLNPI 1376605154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations.
Across 115 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$434
- GSK$346
- AbbVie$278
- Bayer$200
- AstraZeneca$190
- Exact Sciences$154
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $434 |
| GSK | 21 | $346 |
| AbbVie | 8 | $278 |
| Bayer | 4 | $200 |
| AstraZeneca | 12 | $190 |
| Exact Sciences | 7 | $154 |
| Amgen | 4 | $141 |
| Dexcom, Inc. | 3 | $132 |
| Merck | 7 | $97 |
| Idorsia Pharmaceuticals US Inc | 4 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $71 |
| Pfizer | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Halozyme Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Inogen, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,648 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other family in Sebring
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.